Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals Presented in part at the 32nd annual meeting of the Society for Maternal-Fetal Medicine, Dallas, TX, Feb. 6-11, 2012.

Sabine Zoghbi Bousleiman, Madeline Murguia Rice, Joan Moss, Allison Todd, Monica Rincon, Gail Mallett, Cynthia Milluzzi, Donna Allard, Karen Dorman, Felecia Ortiz, Francee Johnson, Peggy Reed, Susan Tolivaisa, R. Wapner, C. Ananth, L. Plante, M. Hoffman, S. Lort, A. Ranzini, G. SaadeM. Costantine, J. Brandon, G. Hankins, A. Salazar, A. Tita, W. Andrews, Jorge Tolosa, A. Lawrence, C. Clock, M. Blaser, M. Nichols, Leonardo Pereira, A. Peaceman, M. Dinsmoor, J. Senka, K. Paychek, B. Mercer, J. Bailit, D. Rouse, B. Anderson, J. Tillinghast, M. Jimenez, S. Timlin, S. Blackwell, J. Iams, M. Varner, K. Hill, V. Morby, G. Anderson, E. Thom, L. Doherty, C. Swartz, B. Broderick, P. McGee, Y. Zhao, T. Spangler, G. Sandoval, C. Spong, J. P. Van Dorsten

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective We sought to evaluate the frequency of, and factors associated with, the use of 3 evidence-based interventions: antenatal corticosteroids for fetal lung maturity, progesterone for prevention of recurrent preterm birth, and magnesium sulfate for fetal neuroprotection. Study Design A self-administered survey was conducted from January through May 2011 among obstetricians from 21 hospitals that included 30 questions regarding their knowledge, attitudes, and practice of the 3 evidence-based interventions and the 14-item short version of the Team Climate for Innovation survey. Frequency of use of each intervention was ascertained from an obstetrical cohort of women between January 2010 and February 2011. Results A total of 329 obstetricians (74% response rate) who managed 16,946 deliveries within the obstetrical cohort participated in the survey. More than 90% of obstetricians reported that they incorporated each intervention into routine practice. Actual frequency of administration in women eligible for the treatments was 93% for corticosteroids, 39% for progesterone, and 71% for magnesium sulfate. Provider satisfaction with quality of treatment evidence was 97% for corticosteroids, 82% for progesterone, and 57% for magnesium sulfate. Obstetricians perceived that barriers to treatment were most frequent for progesterone (76%), 30% for magnesium sulfate, and 17% for corticosteroids. Progesterone use was more frequent among patients whose provider reported the quality of the evidence was above average to excellent compared with poor to average (42% vs 25%, respectively; P

Original languageEnglish (US)
Pages (from-to)398e1-398e11
JournalAmerican Journal of Obstetrics and Gynecology
Volume213
Issue number3
DOIs
StatePublished - Sep 1 2015
Externally publishedYes

Fingerprint

Magnesium Sulfate
Progesterone
Adrenal Cortex Hormones
Health Knowledge, Attitudes, Practice
Premature Birth
Climate
Therapeutics
Lung
Surveys and Questionnaires

Keywords

  • antenatal corticosteroids
  • evidence-based interventions
  • magnesium sulfate
  • Maternal-Fetal Medicine Units Network
  • progesterone

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals Presented in part at the 32nd annual meeting of the Society for Maternal-Fetal Medicine, Dallas, TX, Feb. 6-11, 2012. / Bousleiman, Sabine Zoghbi; Rice, Madeline Murguia; Moss, Joan; Todd, Allison; Rincon, Monica; Mallett, Gail; Milluzzi, Cynthia; Allard, Donna; Dorman, Karen; Ortiz, Felecia; Johnson, Francee; Reed, Peggy; Tolivaisa, Susan; Wapner, R.; Ananth, C.; Plante, L.; Hoffman, M.; Lort, S.; Ranzini, A.; Saade, G.; Costantine, M.; Brandon, J.; Hankins, G.; Salazar, A.; Tita, A.; Andrews, W.; Tolosa, Jorge; Lawrence, A.; Clock, C.; Blaser, M.; Nichols, M.; Pereira, Leonardo; Peaceman, A.; Dinsmoor, M.; Senka, J.; Paychek, K.; Mercer, B.; Bailit, J.; Rouse, D.; Anderson, B.; Tillinghast, J.; Jimenez, M.; Timlin, S.; Blackwell, S.; Iams, J.; Varner, M.; Hill, K.; Morby, V.; Anderson, G.; Thom, E.; Doherty, L.; Swartz, C.; Broderick, B.; McGee, P.; Zhao, Y.; Spangler, T.; Sandoval, G.; Spong, C.; Van Dorsten, J. P.

In: American Journal of Obstetrics and Gynecology, Vol. 213, No. 3, 01.09.2015, p. 398e1-398e11.

Research output: Contribution to journalArticle

Bousleiman, SZ, Rice, MM, Moss, J, Todd, A, Rincon, M, Mallett, G, Milluzzi, C, Allard, D, Dorman, K, Ortiz, F, Johnson, F, Reed, P, Tolivaisa, S, Wapner, R, Ananth, C, Plante, L, Hoffman, M, Lort, S, Ranzini, A, Saade, G, Costantine, M, Brandon, J, Hankins, G, Salazar, A, Tita, A, Andrews, W, Tolosa, J, Lawrence, A, Clock, C, Blaser, M, Nichols, M, Pereira, L, Peaceman, A, Dinsmoor, M, Senka, J, Paychek, K, Mercer, B, Bailit, J, Rouse, D, Anderson, B, Tillinghast, J, Jimenez, M, Timlin, S, Blackwell, S, Iams, J, Varner, M, Hill, K, Morby, V, Anderson, G, Thom, E, Doherty, L, Swartz, C, Broderick, B, McGee, P, Zhao, Y, Spangler, T, Sandoval, G, Spong, C & Van Dorsten, JP 2015, 'Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals Presented in part at the 32nd annual meeting of the Society for Maternal-Fetal Medicine, Dallas, TX, Feb. 6-11, 2012.', American Journal of Obstetrics and Gynecology, vol. 213, no. 3, pp. 398e1-398e11. https://doi.org/10.1016/j.ajog.2015.05.005
Bousleiman, Sabine Zoghbi ; Rice, Madeline Murguia ; Moss, Joan ; Todd, Allison ; Rincon, Monica ; Mallett, Gail ; Milluzzi, Cynthia ; Allard, Donna ; Dorman, Karen ; Ortiz, Felecia ; Johnson, Francee ; Reed, Peggy ; Tolivaisa, Susan ; Wapner, R. ; Ananth, C. ; Plante, L. ; Hoffman, M. ; Lort, S. ; Ranzini, A. ; Saade, G. ; Costantine, M. ; Brandon, J. ; Hankins, G. ; Salazar, A. ; Tita, A. ; Andrews, W. ; Tolosa, Jorge ; Lawrence, A. ; Clock, C. ; Blaser, M. ; Nichols, M. ; Pereira, Leonardo ; Peaceman, A. ; Dinsmoor, M. ; Senka, J. ; Paychek, K. ; Mercer, B. ; Bailit, J. ; Rouse, D. ; Anderson, B. ; Tillinghast, J. ; Jimenez, M. ; Timlin, S. ; Blackwell, S. ; Iams, J. ; Varner, M. ; Hill, K. ; Morby, V. ; Anderson, G. ; Thom, E. ; Doherty, L. ; Swartz, C. ; Broderick, B. ; McGee, P. ; Zhao, Y. ; Spangler, T. ; Sandoval, G. ; Spong, C. ; Van Dorsten, J. P. / Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals Presented in part at the 32nd annual meeting of the Society for Maternal-Fetal Medicine, Dallas, TX, Feb. 6-11, 2012. In: American Journal of Obstetrics and Gynecology. 2015 ; Vol. 213, No. 3. pp. 398e1-398e11.
@article{e8cb175aa64946e8850466020e017324,
title = "Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals Presented in part at the 32nd annual meeting of the Society for Maternal-Fetal Medicine, Dallas, TX, Feb. 6-11, 2012.",
abstract = "Objective We sought to evaluate the frequency of, and factors associated with, the use of 3 evidence-based interventions: antenatal corticosteroids for fetal lung maturity, progesterone for prevention of recurrent preterm birth, and magnesium sulfate for fetal neuroprotection. Study Design A self-administered survey was conducted from January through May 2011 among obstetricians from 21 hospitals that included 30 questions regarding their knowledge, attitudes, and practice of the 3 evidence-based interventions and the 14-item short version of the Team Climate for Innovation survey. Frequency of use of each intervention was ascertained from an obstetrical cohort of women between January 2010 and February 2011. Results A total of 329 obstetricians (74{\%} response rate) who managed 16,946 deliveries within the obstetrical cohort participated in the survey. More than 90{\%} of obstetricians reported that they incorporated each intervention into routine practice. Actual frequency of administration in women eligible for the treatments was 93{\%} for corticosteroids, 39{\%} for progesterone, and 71{\%} for magnesium sulfate. Provider satisfaction with quality of treatment evidence was 97{\%} for corticosteroids, 82{\%} for progesterone, and 57{\%} for magnesium sulfate. Obstetricians perceived that barriers to treatment were most frequent for progesterone (76{\%}), 30{\%} for magnesium sulfate, and 17{\%} for corticosteroids. Progesterone use was more frequent among patients whose provider reported the quality of the evidence was above average to excellent compared with poor to average (42{\%} vs 25{\%}, respectively; P",
keywords = "antenatal corticosteroids, evidence-based interventions, magnesium sulfate, Maternal-Fetal Medicine Units Network, progesterone",
author = "Bousleiman, {Sabine Zoghbi} and Rice, {Madeline Murguia} and Joan Moss and Allison Todd and Monica Rincon and Gail Mallett and Cynthia Milluzzi and Donna Allard and Karen Dorman and Felecia Ortiz and Francee Johnson and Peggy Reed and Susan Tolivaisa and R. Wapner and C. Ananth and L. Plante and M. Hoffman and S. Lort and A. Ranzini and G. Saade and M. Costantine and J. Brandon and G. Hankins and A. Salazar and A. Tita and W. Andrews and Jorge Tolosa and A. Lawrence and C. Clock and M. Blaser and M. Nichols and Leonardo Pereira and A. Peaceman and M. Dinsmoor and J. Senka and K. Paychek and B. Mercer and J. Bailit and D. Rouse and B. Anderson and J. Tillinghast and M. Jimenez and S. Timlin and S. Blackwell and J. Iams and M. Varner and K. Hill and V. Morby and G. Anderson and E. Thom and L. Doherty and C. Swartz and B. Broderick and P. McGee and Y. Zhao and T. Spangler and G. Sandoval and C. Spong and {Van Dorsten}, {J. P.}",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.ajog.2015.05.005",
language = "English (US)",
volume = "213",
pages = "398e1--398e11",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals Presented in part at the 32nd annual meeting of the Society for Maternal-Fetal Medicine, Dallas, TX, Feb. 6-11, 2012.

AU - Bousleiman, Sabine Zoghbi

AU - Rice, Madeline Murguia

AU - Moss, Joan

AU - Todd, Allison

AU - Rincon, Monica

AU - Mallett, Gail

AU - Milluzzi, Cynthia

AU - Allard, Donna

AU - Dorman, Karen

AU - Ortiz, Felecia

AU - Johnson, Francee

AU - Reed, Peggy

AU - Tolivaisa, Susan

AU - Wapner, R.

AU - Ananth, C.

AU - Plante, L.

AU - Hoffman, M.

AU - Lort, S.

AU - Ranzini, A.

AU - Saade, G.

AU - Costantine, M.

AU - Brandon, J.

AU - Hankins, G.

AU - Salazar, A.

AU - Tita, A.

AU - Andrews, W.

AU - Tolosa, Jorge

AU - Lawrence, A.

AU - Clock, C.

AU - Blaser, M.

AU - Nichols, M.

AU - Pereira, Leonardo

AU - Peaceman, A.

AU - Dinsmoor, M.

AU - Senka, J.

AU - Paychek, K.

AU - Mercer, B.

AU - Bailit, J.

AU - Rouse, D.

AU - Anderson, B.

AU - Tillinghast, J.

AU - Jimenez, M.

AU - Timlin, S.

AU - Blackwell, S.

AU - Iams, J.

AU - Varner, M.

AU - Hill, K.

AU - Morby, V.

AU - Anderson, G.

AU - Thom, E.

AU - Doherty, L.

AU - Swartz, C.

AU - Broderick, B.

AU - McGee, P.

AU - Zhao, Y.

AU - Spangler, T.

AU - Sandoval, G.

AU - Spong, C.

AU - Van Dorsten, J. P.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Objective We sought to evaluate the frequency of, and factors associated with, the use of 3 evidence-based interventions: antenatal corticosteroids for fetal lung maturity, progesterone for prevention of recurrent preterm birth, and magnesium sulfate for fetal neuroprotection. Study Design A self-administered survey was conducted from January through May 2011 among obstetricians from 21 hospitals that included 30 questions regarding their knowledge, attitudes, and practice of the 3 evidence-based interventions and the 14-item short version of the Team Climate for Innovation survey. Frequency of use of each intervention was ascertained from an obstetrical cohort of women between January 2010 and February 2011. Results A total of 329 obstetricians (74% response rate) who managed 16,946 deliveries within the obstetrical cohort participated in the survey. More than 90% of obstetricians reported that they incorporated each intervention into routine practice. Actual frequency of administration in women eligible for the treatments was 93% for corticosteroids, 39% for progesterone, and 71% for magnesium sulfate. Provider satisfaction with quality of treatment evidence was 97% for corticosteroids, 82% for progesterone, and 57% for magnesium sulfate. Obstetricians perceived that barriers to treatment were most frequent for progesterone (76%), 30% for magnesium sulfate, and 17% for corticosteroids. Progesterone use was more frequent among patients whose provider reported the quality of the evidence was above average to excellent compared with poor to average (42% vs 25%, respectively; P

AB - Objective We sought to evaluate the frequency of, and factors associated with, the use of 3 evidence-based interventions: antenatal corticosteroids for fetal lung maturity, progesterone for prevention of recurrent preterm birth, and magnesium sulfate for fetal neuroprotection. Study Design A self-administered survey was conducted from January through May 2011 among obstetricians from 21 hospitals that included 30 questions regarding their knowledge, attitudes, and practice of the 3 evidence-based interventions and the 14-item short version of the Team Climate for Innovation survey. Frequency of use of each intervention was ascertained from an obstetrical cohort of women between January 2010 and February 2011. Results A total of 329 obstetricians (74% response rate) who managed 16,946 deliveries within the obstetrical cohort participated in the survey. More than 90% of obstetricians reported that they incorporated each intervention into routine practice. Actual frequency of administration in women eligible for the treatments was 93% for corticosteroids, 39% for progesterone, and 71% for magnesium sulfate. Provider satisfaction with quality of treatment evidence was 97% for corticosteroids, 82% for progesterone, and 57% for magnesium sulfate. Obstetricians perceived that barriers to treatment were most frequent for progesterone (76%), 30% for magnesium sulfate, and 17% for corticosteroids. Progesterone use was more frequent among patients whose provider reported the quality of the evidence was above average to excellent compared with poor to average (42% vs 25%, respectively; P

KW - antenatal corticosteroids

KW - evidence-based interventions

KW - magnesium sulfate

KW - Maternal-Fetal Medicine Units Network

KW - progesterone

UR - http://www.scopus.com/inward/record.url?scp=84940460956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940460956&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2015.05.005

DO - 10.1016/j.ajog.2015.05.005

M3 - Article

C2 - 25957021

AN - SCOPUS:84940460956

VL - 213

SP - 398e1-398e11

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 3

ER -